Innovation is part of the Bioinsectis core, a distinctive trait that allows us to anticipate the needs of the market and our customers.

We draw on our extensive experience to turn our knowledge into reality.

0 %
Investment in R&D
+ 0
Years of experience in bioinsecticides of microbial origin

Highly qualified technical team

R&D projects awarded

R&D projects:

CIVAGEN

(2017-2019)

The development of new technologies to produce an innovative generation of bioionsecticides based on baculovirus (CIVaGen)” Knowledge Transfer Project (UPNA-Bioinsectis collaboration) financed by the Navarran Government. The general objective was to design, develop and apply techniques, strategies and methods that would serve as the basis to produce a new generation of bioinsecticides based on baculovirus (Bio-Bac) that would be competitive with existing pesticides (biological or chemical) in the market.

 

more info

BLATELLA

(2019-2021)

Development of microbial insecticides to combat synanthropic cockroaches including Blattella germánica. Knowledge Transfer Project (UPNa – Nutrinsect – Bioinsectis collaboration) funded by the Government of Navarra. The general objective was to characterize new strains of Bacillus thuringiensis (Bt), as an active ingredient (AI) of microbial insecticides, effective in combatting populations of synanthropic cockroaches, and particularly Germanic Blattella, in Navarra. The aim was to a) determine the composition of innovative Bt culture media, to lower the cost of industrial production of the active ingredient, and b) to characterize new molecules that had synergistic interactions with the active ingredient to obtain insecticidal formulations with greater insecticidal power.

more info

BIO-MICRO

(2019-2021)

Development of a new generation of microbial insecticides. The NEOTEC Project was financed by CDTI. The project obtained the highest score in the year of its call. The general objective of the BIOINSECTIS Business Plan is to develop innovative methods and technologies that effectively contribute to the development of a new generation of microbial insecticides. These bioinsecticides will be based mainly on baculovirus and bacteria, or molecules synthesized by them, which will bring together a series of insecticidal properties that make them competitive when compared to the most widely used insecticides (chemical or biological) on the market.

more info

MOSQUITOS

(2020-2022)

Development of new bioinsecticides based on Bacillus thuringiensis (Bt) for the control of the tiger mosquito (Aedes albopictus) and optimization of toxin production. Knowledge Transfer Project (UPNa – IdaB / CSIC – Bioinsectis collaboration) funded by the Navarran Government. The objective of the project is the identification of new insecticidal genes and the development of molecular tools that allow us to obtain highly effective active ingredients for the control of pests in general and of Aedes albopictus (tiger mosquito) in particular.

more info

CIVAGEN CCHH

(2021-2023)

Application of CiVaGen technology, previously developed by Bioinsectis, to design and develop effective baculovirus-based products against groups of pests that affect the most important horticultural crops. These technological developments will present unprecedented characteristics with respect to currently commercialized baculovirus-based products. The technological developments of Bioinsectis, which can be protected by patent, will be valid to combat several pests using a single product, which signifies a huge advantage from a technical, commercial, and economic point of view.

more info